Key facts
- Kapsera’s last known valuation is $3.2M (Feb 2019).
- It has raised $6.6M; the latest was Later Stage VC in Sep 2025.
- Notable investors include Bpifrance, The Yield Lab, Banque des Territoires, Demeter Partners, Demea Sustainable Investment — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Kapsera
- ·The full record, as it builds
Funding rounds
No funding rounds for Kapsera are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kapsera
Developer of bio-sourced and biodegradable microcapsules designed to offer better agricultural services. The company's microcapsules make it possible to formulate beneficial microorganisms from plants and to release them in the field in an active form, enabling farmers to protect agriculture, soils, and biodiversity and promote sustainability and productivity for agriculture.
- Sector
- Materials and Resources
- HQ
- Bordeaux, France
- Founded
- 2018
- Employees
- 27
- Website
- kapsera.com/
- Ownership
- Privately Held (backing)
Kapsera doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kapsera shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kapsera in its N-PORT filings yet. We sweep new filings monthly.